Institutional Ownership
Zevra Therapeutics Inc
CUSIP 488445206COM NEWZVRAQ1 2026
13D / 13G Filings
23
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
11.1%
Max % of class reported
Institutional Holders
143
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
23 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Woodline Partners LP | 13G/A | 6.2% | 3.48M | SEC |
| 2 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G/A | 4.0% | 2.23M | SEC |
| 3 | Feb 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 4.4% | 2.34M | SEC |
| 4 | Feb 12, 2025 | Adage Capital Management, L.P. | 13G | 6.8% | 3.65M | SEC |
| 5 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 7.6% | 4.08M | SEC |
| 6 | Nov 14, 2024 | Nantahala Capital Management, LLC | 13G/A | 5.6% | 2.92M | SEC |
| 7 | Nov 14, 2024 | Woodline Partners LP | 13G | 7.7% | 4.05M | SEC |
| 8 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 5.2% | 2.76M | SEC |
| 9 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 5.2% | 2.76M | SEC |
| 10 | Feb 14, 2024 | Nantahala Capital Management, LLC | 13G | 6.2% | 2.45M | SEC |
13 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Zevra Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 4.46M | $41.53M |
| 2 | Woodline Partners LP | 3.45M | $32.16M |
| 3 | Fmr LLC | 3.21M | $29.93M |
| 4 | Nantahala Capital Management, LLC | 2.52M | $23.50M |
| 5 | State Street Corp | 1.56M | $14.55M |
| 6 | Geode Capital Management, LLC | 1.37M | $12.79M |
| 7 | Aigh Capital Management LLC | 1.20M | $11.18M |
| 8 | Morgan Stanley | 1.19M | $11.11M |
| 9 | Legal & General Group PLC | 1.16M | $10.84M |
| 10 | Point72 Asset Management, L.P. | 1.16M | $10.78M |